awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28552337-E8F6655F-34EA-461A-BBC9-31CFABDA3CB2
Q28552337-E8F6655F-34EA-461A-BBC9-31CFABDA3CB2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28552337-E8F6655F-34EA-461A-BBC9-31CFABDA3CB2
Mechanistic Approaches to Improve Correction of the Most Common Disease-Causing Mutation in Cystic Fibrosis
P2860
Q28552337-E8F6655F-34EA-461A-BBC9-31CFABDA3CB2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28552337-E8F6655F-34EA-461A-BBC9-31CFABDA3CB2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
70ceb03a5a2937eddd64b4de50f28bcf75ed9e56
P2860
A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial.